Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: May, 2018 | Pages:
112 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
The global Orphan Drugs market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.
GCC plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of xx%.
This report studies the Orphan Drugs development status and future trend in GCC, focuses on top players in GCC, also splits Orphan Drugs by type and by Application, to fully and deeply research and reveal the market general situation and future forecast.
The major players in GCC market include
Novartis AG
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
Sanofi S.A.
Alexion Pharmaceuticals, Inc.
Eli Lilly and Company
Novo Nordisk A/S
AstraZeneca
Eisai Co., Ltd.
Daiichi Sankyo Company Limited
Bayer AG
GlaxoSmithKline
Merck & Co., Inc.
Johnson & Johnson
Biogen, Inc.
Shire
Amgen, Inc.
On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
Oncology
Gastrointestinal
Pulmonary
Neurology
Hematology
Cardio-vascular
Metabolic disorders
Endocrinology
Infectious diseases
Others
On the basis of the end users/Application, this report covers
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
GCC Orphan Drugs Market Research Report 2018
1 Orphan Drugs Overview
1.1 Product Overview and Scope of Orphan Drugs
1.2 Classification of Orphan Drugs by Product Category
1.2.1 GCC Orphan Drugs Sales (K Units) Comparison by Type (2013-2025)
1.2.2 GCC Orphan Drugs Sales (K Units) Market Share by Type in 2017
1.2.3 Oncology
1.2.4 Gastrointestinal
1.2.5 Pulmonary
1.2.6 Neurology
1.2.7 Hematology
1.2.8 Cardio-vascular
1.2.9 Metabolic disorders
1.2.10 Endocrinology
1.2.11 Infectious diseases
1.2.12 Others
1.3 GCC Orphan Drugs Market by Application/End Users
1.3.1 GCC Orphan Drugs Sales (K Units) and Market Share Comparison by Application (2013-2025)
1.3.2 Hospital Pharmacies
1.3.3 Speciality Pharmacies
1.3.4 Retail pharmacies
1.3.5 Others
1.4 GCC Revenue and Sales of Orphan Drugs (2013-2025)
1.4.1 GCC Orphan Drugs Sales (K Units) and Growth Rate (%)(2013-2025)
1.4.2 GCC Orphan Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
2 GCC Orphan Drugs Market Competition by Players/Manufacturers
2.1 GCC Orphan Drugs Sales (K Units) and Market Share (%) of Key Players/Manufacturers (2013-2018)
2.2 GCC Orphan Drugs Revenue and Share by Players/Manufacturers (2013-2018)
2.3 GCC Orphan Drugs Average Price (USD/Unit) by Players/Manufacturers (2013-2018)
2.4 GCC Orphan Drugs Market Competitive Situation and Trends
2.4.1 GCC Orphan Drugs Market Concentration Rate
2.4.2 GCC Orphan Drugs Market Share of Top 3 and Top 5 Players/Manufacturers
2.4.3 Mergers & Acquisitions, Expansion in GCC Market
2.5 GCC Players/Manufacturers Orphan Drugs Manufacturing Base Distribution, Sales Area, Product Type
3 GCC Orphan Drugs Sales and Revenue (Value) by Type (2013-2018)
3.1 GCC Orphan Drugs Sales (K Units) and Market Share by Type/ Product Category (2013-2018)
3.2 GCC Orphan Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
3.3 GCC Orphan Drugs Price (USD/Unit) by Type (2013-2018)
3.4 GCC Orphan Drugs Sales Growth Rate (%) by Type (2013-2018)
4 GCC Orphan Drugs Sales by Application (2013-2018)
4.1 GCC Orphan Drugs Sales (K Units) and Market Share by Application (2013-2018)
4.2 GCC Orphan Drugs Sales Growth Rate (%) by Application (2013-2018)
4.3 Market Drivers and Opportunities
5 GCC Orphan Drugs Players/Suppliers Profiles and Sales Data
5.1 Novartis AG
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Orphan Drugs Product Category, Application and Specification
5.1.2.1 Product A
5.1.2.2 Product B
5.1.3 Novartis AG Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.1.4 Main Business/Business Overview
5.2 Bristol-Myers Squibb Company
5.2.1 Company Basic Information, Manufacturing Base and Competitors
5.2.2 Orphan Drugs Product Category, Application and Specification
5.2.2.1 Product A
5.2.2.2 Product B
5.2.3 Bristol-Myers Squibb Company Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.2.4 Main Business/Business Overview
5.3 Celgene Corporation
5.3.1 Company Basic Information, Manufacturing Base and Competitors
5.3.2 Orphan Drugs Product Category, Application and Specification
5.3.2.1 Product A
5.3.2.2 Product B
5.3.3 Celgene Corporation Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.3.4 Main Business/Business Overview
5.4 F. Hoffmann-La Roche Ltd.
5.4.1 Company Basic Information, Manufacturing Base and Competitors
5.4.2 Orphan Drugs Product Category, Application and Specification
5.4.2.1 Product A
5.4.2.2 Product B
5.4.3 F. Hoffmann-La Roche Ltd. Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.4.4 Main Business/Business Overview
5.5 Pfizer, Inc.
5.5.1 Company Basic Information, Manufacturing Base and Competitors
5.5.2 Orphan Drugs Product Category, Application and Specification
5.5.2.1 Product A
5.5.2.2 Product B
5.5.3 Pfizer, Inc. Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.5.4 Main Business/Business Overview
5.6 Sanofi S.A.
5.6.1 Company Basic Information, Manufacturing Base and Competitors
5.6.2 Orphan Drugs Product Category, Application and Specification
5.6.2.1 Product A
5.6.2.2 Product B
5.6.3 Sanofi S.A. Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.6.4 Main Business/Business Overview
5.7 Alexion Pharmaceuticals, Inc.
5.7.1 Company Basic Information, Manufacturing Base and Competitors
5.7.2 Orphan Drugs Product Category, Application and Specification
5.7.2.1 Product A
5.7.2.2 Product B
5.7.3 Alexion Pharmaceuticals, Inc. Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.7.4 Main Business/Business Overview
5.8 Eli Lilly and Company
5.8.1 Company Basic Information, Manufacturing Base and Competitors
5.8.2 Orphan Drugs Product Category, Application and Specification
5.8.2.1 Product A
5.8.2.2 Product B
5.8.3 Eli Lilly and Company Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.8.4 Main Business/Business Overview
5.9 Novo Nordisk A/S
5.9.1 Company Basic Information, Manufacturing Base and Competitors
5.9.2 Orphan Drugs Product Category, Application and Specification
5.9.2.1 Product A
5.9.2.2 Product B
5.9.3 Novo Nordisk A/S Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.9.4 Main Business/Business Overview
5.10 AstraZeneca
5.10.1 Company Basic Information, Manufacturing Base and Competitors
5.10.2 Orphan Drugs Product Category, Application and Specification
5.10.2.1 Product A
5.10.2.2 Product B
5.10.3 AstraZeneca Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
5.10.4 Main Business/Business Overview
5.11 Eisai Co., Ltd.
5.12 Daiichi Sankyo Company Limited
5.13 Bayer AG
5.14 GlaxoSmithKline
5.15 Merck & Co., Inc.
5.16 Johnson & Johnson
5.17 Biogen, Inc.
5.18 Shire
5.19 Amgen, Inc.
6 Orphan Drugs Manufacturing Cost Analysis
6.1 Orphan Drugs Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Orphan Drugs
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Orphan Drugs Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Orphan Drugs Major Manufacturers in 2017
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 GCC Orphan Drugs Market Size (Sales and Revenue) Forecast (2018-2025)
10.1 GCC Orphan Drugs Sales (K Units), Revenue (Million USD) Forecast (2018-2025)
10.2 GCC Orphan Drugs Sales (K Units) Forecast by Type (2018-2025)
10.3 GCC Orphan Drugs Sales (K Units) Forecast by Application (2018-2025)
11 Research Findings and Conclusion
List of Tables and Figures
Figure GCC Market Size (Million USD) Status and Outlook (2013-2025)
Table Orphan Drugs Sales (K Units) and Revenue (Million USD) Market Split by Product Type
Table Orphan Drugs Sales (K Units) by Application (2017-2025)
Figure Product Picture of Orphan Drugs
Table GCC Orphan Drugs Sales (K Units) and Growth Rate (%) Comparison by Type (Product Category) (2013-2025)
Figure GCC Orphan Drugs Sales Volume Market Share by Type in 2017
Figure Oncology Product Picture
Figure Gastrointestinal Product Picture
Figure Pulmonary Product Picture
Figure Neurology Product Picture
Figure Hematology Product Picture
Figure Cardio-vascular Product Picture
Figure Metabolic disorders Product Picture
Figure Endocrinology Product Picture
Figure Infectious diseases Product Picture
Figure Others Product Picture
Figure GCC Orphan Drugs Sales (K Units) Comparison by Application (2013-2025)
Figure GCC Sales Market Share (%) of Orphan Drugs by Application in 2017
Figure Hospital Pharmacies Examples
Figure Speciality Pharmacies Examples
Figure Retail pharmacies Examples
Figure Others Examples
Figure GCC Orphan Drugs Sales (K Units) and Growth Rate (%)(2013-2025)
Figure GCC Orphan Drugs Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table GCC Orphan Drugs Sales of Key Players/Manufacturers (2013-2018)
Table GCC Orphan Drugs Sales Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 GCC Orphan Drugs Sales Share (%) by Players/Manufacturers
Figure 2017 GCC Orphan Drugs Sales Share (%) by Players/Manufacturers
Table GCC Orphan Drugs Revenue by Players/Manufacturers (2013-2018)
Table GCC Orphan Drugs Revenue Market Share (%) by Players/Manufacturers (2013-2018)
Figure 2017 GCC Orphan Drugs Revenue Share (%) by Players/Manufacturers
Figure 2017 GCC Orphan Drugs Revenue Share (%) by Players/Manufacturers
Table GCC Market Orphan Drugs Average Price (USD/Unit) of Key Players/Manufacturers (2013-2018)
Figure GCC Market Orphan Drugs Average Price (USD/Unit) of Key Players/Manufacturers in 2017
Figure GCC Orphan Drugs Market Share of Top 3 Players/Manufacturers
Figure GCC Orphan Drugs Market Share of Top 5 Players/Manufacturers
Table GCC Players/Manufacturers Orphan Drugs Manufacturing Base Distribution and Sales Area
Table GCC Players/Manufacturers Orphan Drugs Product Category
Table GCC Orphan Drugs Sales (K Units) by Type (2013-2018)
Table GCC Orphan Drugs Sales Share (%) by Type (2013-2018)
Figure GCC Orphan Drugs Sales Share (%) by Type (2013-2018)
Figure GCC Orphan Drugs Sales Market Share (%) by Type in 2017
Table GCC Orphan Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table GCC Orphan Drugs Revenue Market Share (%) by Type (2013-2018)
Figure Revenue Market Share of Orphan Drugs by Type (2013-2018)
Figure Revenue Market Share of Orphan Drugs by Type in 2017
Table GCC Orphan Drugs Price (USD/Unit) by Type (2013-2018)
Figure GCC Orphan Drugs Sales Growth Rate (%) by Type (2013-2018)
Table GCC Orphan Drugs Sales (K Units) by Application (2013-2018)
Table GCC Orphan Drugs Sales Market Share (%) by Application (2013-2018)
Figure GCC Orphan Drugs Sales Market Share (%) by Application (2013-2018)
Figure GCC Orphan Drugs Sales Market Share (%) by Application in 2017
Table GCC Orphan Drugs Sales Growth Rate (%) by Application (2013-2018)
Figure GCC Orphan Drugs Sales Growth Rate (%) by Application (2013-2018)
Table Novartis AG Orphan Drugs Basic Information List
Table Novartis AG Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Novartis AG Orphan Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Novartis AG Orphan Drugs Sales Market Share (%) in GCC (2013-2018)
Figure Novartis AG Orphan Drugs Revenue Market Share (%) in GCC (2013-2018)
Table Bristol-Myers Squibb Company Orphan Drugs Basic Information List
Table Bristol-Myers Squibb Company Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Bristol-Myers Squibb Company Orphan Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Bristol-Myers Squibb Company Orphan Drugs Sales Market Share (%) in GCC (2013-2018)
Figure Bristol-Myers Squibb Company Orphan Drugs Revenue Market Share (%) in GCC (2013-2018)
Table Celgene Corporation Orphan Drugs Basic Information List
Table Celgene Corporation Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Celgene Corporation Orphan Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Celgene Corporation Orphan Drugs Sales Market Share (%) in GCC (2013-2018)
Figure Celgene Corporation Orphan Drugs Revenue Market Share (%) in GCC (2013-2018)
Table F. Hoffmann-La Roche Ltd. Orphan Drugs Basic Information List
Table F. Hoffmann-La Roche Ltd. Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure F. Hoffmann-La Roche Ltd. Orphan Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure F. Hoffmann-La Roche Ltd. Orphan Drugs Sales Market Share (%) in GCC (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Orphan Drugs Revenue Market Share (%) in GCC (2013-2018)
Table Pfizer, Inc. Orphan Drugs Basic Information List
Table Pfizer, Inc. Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Pfizer, Inc. Orphan Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Pfizer, Inc. Orphan Drugs Sales Market Share (%) in GCC (2013-2018)
Figure Pfizer, Inc. Orphan Drugs Revenue Market Share (%) in GCC (2013-2018)
Table Sanofi S.A. Orphan Drugs Basic Information List
Table Sanofi S.A. Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Sanofi S.A. Orphan Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Sanofi S.A. Orphan Drugs Sales Market Share (%) in GCC (2013-2018)
Figure Sanofi S.A. Orphan Drugs Revenue Market Share (%) in GCC (2013-2018)
Table Alexion Pharmaceuticals, Inc. Orphan Drugs Basic Information List
Table Alexion Pharmaceuticals, Inc. Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Alexion Pharmaceuticals, Inc. Orphan Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Alexion Pharmaceuticals, Inc. Orphan Drugs Sales Market Share (%) in GCC (2013-2018)
Figure Alexion Pharmaceuticals, Inc. Orphan Drugs Revenue Market Share (%) in GCC (2013-2018)
Table Eli Lilly and Company Orphan Drugs Basic Information List
Table Eli Lilly and Company Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Eli Lilly and Company Orphan Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Eli Lilly and Company Orphan Drugs Sales Market Share (%) in GCC (2013-2018)
Figure Eli Lilly and Company Orphan Drugs Revenue Market Share (%) in GCC (2013-2018)
Table Novo Nordisk A/S Orphan Drugs Basic Information List
Table Novo Nordisk A/S Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure Novo Nordisk A/S Orphan Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure Novo Nordisk A/S Orphan Drugs Sales Market Share (%) in GCC (2013-2018)
Figure Novo Nordisk A/S Orphan Drugs Revenue Market Share (%) in GCC (2013-2018)
Table AstraZeneca Orphan Drugs Basic Information List
Table AstraZeneca Orphan Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2013-2018)
Figure AstraZeneca Orphan Drugs Sales (K Units) and Growth Rate (%)(2013-2018)
Figure AstraZeneca Orphan Drugs Sales Market Share (%) in GCC (2013-2018)
Figure AstraZeneca Orphan Drugs Revenue Market Share (%) in GCC (2013-2018)
Table Eisai Co., Ltd. Orphan Drugs Basic Information List
Table Daiichi Sankyo Company Limited Orphan Drugs Basic Information List
Table Bayer AG Orphan Drugs Basic Information List
Table GlaxoSmithKline Orphan Drugs Basic Information List
Table Merck & Co., Inc. Orphan Drugs Basic Information List
Table Johnson & Johnson Orphan Drugs Basic Information List
Table Biogen, Inc. Orphan Drugs Basic Information List
Table Shire Orphan Drugs Basic Information List
Table Amgen, Inc. Orphan Drugs Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Orphan Drugs
Figure Manufacturing Process Analysis of Orphan Drugs
Figure Orphan Drugs Industrial Chain Analysis
Table Raw Materials Sources of Orphan Drugs Major Players/Manufacturers in 2017
Table Major Buyers of Orphan Drugs
Table Distributors/Traders List
Figure GCC Orphan Drugs Sales (K Units) and Growth Rate (%) Forecast (2018-2025)
Figure GCC Orphan Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure GCC Orphan Drugs Price (USD/Unit) Trend Forecast (2018-2025)
Table GCC Orphan Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure GCC Orphan Drugs Sales (K Units) Forecast by Type (2018-2025)
Figure GCC Orphan Drugs Sales Volume Market Share Forecast by Type in 2025
Table GCC Orphan Drugs Sales (K Units) Forecast by Application (2018-2025)
Figure GCC Orphan Drugs Sales Volume Market Share Forecast by Application (2018-2025)
Figure GCC Orphan Drugs Sales Volume Market Share Forecast by Application in 2025
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
